Metformin-associated lactic acidosis and temporary ileostomy: A case report

Journal of Medical Case Reports

Volumn 8, Issue 1, 2014, Pages

  Margiani, Carla ^a   Zorcolo, Luigi ^a   Mura, Paolo ^b   Saba, Marcello ^b   Restivo, Angelo ^a   Scintu, Francesco ^a  

^a Department of General Surgery University Colorectal Unit Cittadella Universitaria   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Ileostomy; Lactic acidosis; Metformin

Indexed keywords

ANTINEOPLASTIC AGENT; BICARBONATE; CARBON DIOXIDE; CREATININE; HYDROCHLOROTHIAZIDE PLUS IRBESARTAN; METFORMIN; TAMSULOSIN; ANTIDIABETIC AGENT;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; AGED; ALKALOSIS; ANURIA; ARTICLE; CANCER RADIOTHERAPY; CASE REPORT; CAUCASIAN; CHEMORADIOTHERAPY; COLORECTAL CANCER; CONSCIOUSNESS DISORDER; CREATININE BLOOD LEVEL; DEHYDRATION; DISEASE SEVERITY; EXCISION; HEMODIALYSIS; HUMAN; HYPERTENSION; ILEOSTOMY; INTERNAL JUGULAR VEIN; KIDNEY FUNCTION; LABORATORY TEST; LACTIC ACIDOSIS; MALE; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; PHYSICAL EXAMINATION; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRESSURE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; RECTUM ANTERIOR RESECTION; TACHYPNEA; UREA NITROGEN BLOOD LEVEL; VOMITING; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION; DRUG SURVEILLANCE PROGRAM; RISK FACTOR; TREATMENT OUTCOME; REHYDRATION; TOTAL MESORECTAL EXCISION;

ACIDOSIS, LACTIC; ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED; DIABETES MELLITUS, TYPE 2; DRUG ADMINISTRATION SCHEDULE; HUMANS; HYPOGLYCEMIC AGENTS; ILEOSTOMY; MALE; METFORMIN; RISK FACTORS; TREATMENT OUTCOME;

EID: 84928737531     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-8-449-1     Document Type: Article

References (14)

1. Prospective UK, Diabetes Study (UKPDS) Group: Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998, 352:854-865.
2. A published erratum appears in Lancet 1998, 352:1558.
3. Cohen RD, Woods HF: Metformin and lactic acidosis. Diabetes Care 1999, 22:1010-1011
4. Lalau JD, Race JM: Lactic acidosis in metformin-treated patients: prognostic value of arterial lactate levels and plasma metformin concentrations. Drug Saf 1999, 20:377-384.
5. Renda F, Mura P, Finco G, Ferrazin F, Pani L, Landoni G: Metformin-associated lactic acidosis requiring hospitalization: a national 10 year survey and a systematic literature review. Eur Rev Med Pharmacol Sci 2013, 17(Suppl 1) 45-49.
6. World Health Organization, International Agency for Research on Cancer (WHO/IARC): Higher blood vitamin D levels are associated with significantly decreased colon cancer risk in European populations. Press release no. 198 (22 January 2010). [http://www.iarc.fr/en/media-centre/pr/2010/pdfs/pr198-E.pdf] (accessed 7 November 2014).
7. Janssen-Heijnen ML, Houterman S, Lemmens VE, Louwman MW, Maas HA, Coebergh JW: Prognostic impact of increasing age and co-morbidity in cancer patients: a population-based approach. Crit Rev Oncol Hematol 2005, 55:231-240.
8. Larsson SC, Orsini N, Wolk A Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst 2005, 97:1679-1687.
9. Yang YX, Hennessy S, Lewis JD: Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients. Gastroenterology 2004, 127:1044-1050.
10. Vigneri P, Frasca F, Sciacca L, Pandini G, Vigneri R: Diabetes and cancer. Endocr Relat Cancer 2009, 16:1103-1123.
11. Miller RA, Birnbaum MJ: An energetic tale of AMPK-independent effects of metformin. J Clin Invest 2010, 120:2267-2270
12. Tang CL, Yunos A, Leong AP, Seow-Choen F, Goh HS: Ileostomy output in the early postoperative period. Br J Surg 1995, 82:607.
13. Soybel DI: Adaptation to ileal diversion. Surgery 2001, 129:123-127
14. Messaris E, Sehgal R, Deiling S, Koltun WA, Stewart D, McKenna K, Poritz LS: Dehydration is the most common indication for readmission after diverting ileostomy creation. Dis Colon Rectum 2012, 55:175-180